Diabetic population mortality and cardiovascular risk attributable to hypertension: A decade follow-up from the Tehran Lipid and Glucose Study

被引:22
作者
Bozorgmanesh, Mohammadreza [1 ]
Hadaegh, Farzad [1 ]
Mohebi, Reza [1 ]
Ghanbarian, Arash [1 ]
Eskandari, Fatemeh [1 ]
Azizi, Fereidoun [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, RIES, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, RIES, Tehran, Iran
关键词
Cardiovascular disease; diabetes; hypertension; mortality; population-attributable hazard fraction; ACUTE MYOCARDIAL-INFARCTION; FALSE DISCOVERY RATE; ALL-CAUSE MORTALITY; HEART-ASSOCIATION; NONCOMMUNICABLE DISEASE; PRIMARY PREVENTION; AMERICAN-COLLEGE; UNSTABLE ANGINA; TASK-FORCE; MELLITUS;
D O I
10.3109/08037051.2013.769294
中图分类号
R6 [外科学];
学科分类号
100210 [外科学];
摘要
To determine the extent to which burden of cardiovascular disease (CVD) outcomes among diabetic population is attributable to hypertension. Nine-year follow-up data were secured for 7068 participants aged >= 20 years old, free from CVD at baseline. Cox proportional hazards regression was implemented to estimate hazard ratios (HRs) of hypertension. Population-attributable hazard fraction (PAHF) was used to assess proportion of diabetic population hazard of CVD events and mortality attributable to hypertension. In the whole population, irrespective of diabetes or hypertension status, incidence rate (95% CI) of CVD, coronary heart disease (CHD), as well as CVD and all-cause mortality per 1000 person-year were 8.3 (7.6-9.0), 7.1 (6.5-7.8), 1.8 (1.5-2.1) and 3.9 (3.5-4.5), respectively. Among diabetes participants, hypertension was a risk factor for CHD (HR = 1.63, 95% CI 1.15-2.03), CVD (HR = 1.74, 95% CI 1.50-2.41), CVD mortality (HR = 1.65, 95% CI 0.87-3.12) and all-cause mortality (HR = 1.53, 95% CI 0.97-2.42). HRs, however, were not statistically significant for all-cause or CVD mortality. PAHFs (%) of hypertension was 27.5 (95% CI 8.3-42.6) for CHD, 29.6 (95% CI 10.6-44.4) for CVD, 27.9 (95% CI = 17.2 to 55.7) for CVD mortality and 22.6 (95% CI = 5.9 to 43.4) for all-cause mortality. Our study shows that there is an excess risk of CVD in hypertensive patients with diabetes related to inadequate control of blood pressure.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 47 条
[1]
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]
[Anonymous], 2000, Lancet, V355, P253, DOI [10.1016/S0140-6736(99)12323-7, DOI 10.1016/S0140-6736(99)12323-7]
[3]
Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II [J].
Azizi, Fereidoun ;
Ghanbarian, Arash ;
Momenan, Amir Abbas ;
Hadaegh, Farzad ;
Mirmiran, Parvin ;
Hedayati, Mehdi ;
Mehrabi, Yadollah ;
Zahedi-Asl, Saleh .
TRIALS, 2009, 10
[4]
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[5]
A review of adjusted estimators of attributable risk [J].
Benichou, J .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2001, 10 (03) :195-216
[6]
Benjamini Y, 2001, ANN STAT, V29, P1165
[7]
CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[8]
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials [J].
Boussageon, Remy ;
Bejan-Angoulvant, Theodora ;
Saadatian-Elahi, Mitra ;
Lafont, Sandrine ;
Bergeonneau, Claire ;
Kassai, Behrouz ;
Erpeldinger, Sylvie ;
Wright, James M. ;
Gueyffier, Francois ;
Cornu, Catherine .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[9]
Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study [J].
Bozorgmanesh, M. ;
Hadaegh, F. ;
Sheikholeslami, F. ;
Azizi, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (01) :14-20
[10]
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Hiratzka, LF ;
Jacobs, AK ;
Smith, SC .
CIRCULATION, 2002, 106 (14) :1893-1900